Normal

Allosteric Bioscience, Inc. Signs Sponsored Research Agreement with Dr. Susan Michaelis at Johns Hopkins University for Aging/Longevity-Related Work

Retrieved on: 
Wednesday, January 17, 2024
Research, Technology, Health Technology, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Artificial Intelligence, ABI, Syndrome, Human genetics, Progeria, School, Systems biology, Johns Hopkins University, Cell biology, Molecular biology, SRA, Quantum computing, Genetics, Medical school, Normal, Ageing, Communication, Mutation, Disease, Progerin, Protein, Cell, Pharmaceutical industry

Allosteric Bioscience, Inc. (ABI) has signed a Sponsored Research Agreement (SRA) with Dr. Susan Michaelis at Johns Hopkins University for analysis of chemical leads for modulation (increase or decrease) of key protein targets for Optimizing Aging and Longevity.

Key Points: 
  • Allosteric Bioscience, Inc. (ABI) has signed a Sponsored Research Agreement (SRA) with Dr. Susan Michaelis at Johns Hopkins University for analysis of chemical leads for modulation (increase or decrease) of key protein targets for Optimizing Aging and Longevity.
  • At Johns Hopkins University Dr. Susan Michaelis will manage the analysis.
  • Dr. Michaelis is a leader in aging research and is a Professor in Cell Biology at Johns Hopkins University, School of Medicine.
  • Participation by Dr. Susan Michaelis in the SRA does not constitute or imply endorsement of Allosteric Bioscience, Inc. (Company) by Johns Hopkins University.

Tuscany: Harvest Season For Montecucco DOC and DOCG Begins

Retrieved on: 
Wednesday, September 13, 2023
Cesare Montecucco, Heat, Altitude, Human, Tenuta, Temperature, Merlot, Castel, Climate change, Montenero d'Orcia, DOCG, Weather, Normal, Viticulture, Vermentino, Amiatina, Poggi del Sasso

NEW YORK, Sept. 13, 2023 /PRNewswire-PRWeb/ -- The Montecucco Wine Consortium is pleased to share crucial information regarding the 2023 growing season in the Montecucco DOC and DOCG areas.

Key Points: 
  • NEW YORK, Sept. 13, 2023 /PRNewswire-PRWeb/ -- The Montecucco Wine Consortium is pleased to share crucial information regarding the 2023 growing season in the Montecucco DOC and DOCG areas.
  • Despite the challenging season, our producers did a great job, bringing outstanding quality grapes into the cellar.
  • This season has been marked by unusual weather conditions in the region, with abundant rainfall through late June and several heatwaves, particularly in mid-August.
  • Despite the challenging season, our producers did a great job, bringing outstanding quality grapes into the cellar.

All-new, All-electric 2025 Ram 1500 REV Unveiled at New York International Auto Show with Targeted Range of up to an Unsurpassed 500 Miles

Retrieved on: 
Wednesday, April 5, 2023
First officer (aviation), DNA, Music, Klipsch Audio Technologies, Bev, EV, Ram pickup, 4x4 Evo, Noise, Inorganic polymer, Smartphone, Scorpion, STLA, Torque, Normal, DC, Platinum, New York International Auto Show, Temperature, Blinking, HUD, REV, HDMI, LED, Regeneration, Pirelli, International Auto Show, MUSCULAR, Document, VIN, SAT Subject Test in Mathematics Level 1, EDM, Level 1, Software, Self storage, Television, Video game, Electric motor, Renewable energy, Heavy equipment, Road, Mobile phone, Limited, Stellantis, Ram

The 2025 Ram 1500 REV is available in five trims including Tradesman, Big Horn/Lone Star, Laramie, Limited and, introducing an all-new trim, Tungsten.

Key Points: 
  • The 2025 Ram 1500 REV is available in five trims including Tradesman, Big Horn/Lone Star, Laramie, Limited and, introducing an all-new trim, Tungsten.
  • The all-new Ram 1500 REV XR with class-shattering range will follow the introduction of the all-electric Ram 1500 REV.
  • The new Ram 1500 REV Tungsten trim gives customers an ultra-premium experience while staying true to the hardworking nature of the Ram 1500.
  • Other EV gauges include current power, regen, range and battery temperature
    The 2025 Ram 1500 REV features a 10.25-inch passenger screen.

Energy Industry "Who's Who" to Convene in Dallas Feb. 15-16 on Future of Energy

Retrieved on: 
Monday, February 13, 2023
Commodity, Entrepreneurship, Interview, George Bush Center for Intelligence, World Energy Outlook, Rise, Name, Consumer, Normal, Renewable energy

WHAT: SMU Cox Maguire Energy Institute, in collaboration with the George W. Bush Presidential Center, presents “ Energy Outlook '23 : Stewarding a Sensible Energy Future.” Approximately 300 who’s who of the energy industry will convene in Dallas for the two-day, invitation-only symposium.

Key Points: 
  • WHAT: SMU Cox Maguire Energy Institute, in collaboration with the George W. Bush Presidential Center, presents “ Energy Outlook '23 : Stewarding a Sensible Energy Future.” Approximately 300 who’s who of the energy industry will convene in Dallas for the two-day, invitation-only symposium.
  • The event will focus broadly on the future of energy and brings together some of the biggest names in the industry, comprised of leaders, innovators, visionaries, consumers and corporate partners.
  • It will be the largest gathering of energy thought leaders in North Texas history and feature nearly 20 sessions and 50 speakers/presenters.
  • WHO Energy producers, investors, policymakers and consumer organizations from across the energy industry will attend the event.

WICKES GROUP PLC: Director / PDMR Shareholding

Retrieved on: 
Thursday, September 29, 2022
Tranche, Normal, Exercise, LTIP, Achievement, Listing, Lease

The options granted under the Listing Rule 9.4.2 Buyout Award will vest on 9 September 2023 (Tranche 1) and 25 March 2024 (Tranche 2).

Key Points: 
  • The options granted under the Listing Rule 9.4.2 Buyout Award will vest on 9 September 2023 (Tranche 1) and 25 March 2024 (Tranche 2).
  • Further details can be found in the Wickes Group Plc Annual Report and Accounts 2021.
  • If options vest they will normally be exercisable until the tenth anniversary of the Grant Date.
  • The Notification of Dealing Forms for each PDMR can be found below.

NONPROFIT EXPANDS TO ALL 50 STATES TO HELP KIDS WITH LIFE-THREATENING CONDITIONS "BE A KID AGAIN"

Retrieved on: 
Wednesday, August 10, 2022
Multimedia, Sickle cell disease, Happiness, Cancer, Normal, Museum, Hope, St. Louis Fed Financial Stress Index, Cedar Fair, COVID-19, Kids Again, Family, Cystic fibrosis, Child, Water, A Kid, Conditional sentence, Adventure, Meal, Volunteering, Sibling, Cerebral palsy, Amusement park, Toy

COLUMBUS, Ohio, Aug. 10, 2022 /PRNewswire/ -- Once a localized, regional nonprofit, A Kid Again is thrilled to announce its national expansion, now serving more than 9,000 families in communities in all 50 states – an impact on 46,000 individuals.

Key Points: 
  • A Kid Again is thrilled to announce its national expansion, now serving more than 9,000 families in all 50 states.
  • Nationwide, more than 1.5 million children have a life-threatening condition like cancer, heart conditions, Cerebral Palsy, sickle cell disease, cystic fibrosis and more.
  • That means 1.5 million kids and their families face endless doctor's visits, surgeries, treatments, medical bills, and the emotional toll of chronic illness.
  • That's why the nonprofit A Kid Again was founded, to bring hope, happiness, and healing to kids with life-threatening conditions and their families.

Global Anemia And Other Blood Disorder Drugs Markets, 2016-2021, 2021-2026F, 2031F by Type, Distribution Channel, Route of Administration, Anemia Type - ResearchAndMarkets.com

Retrieved on: 
Friday, July 29, 2022
General Health, Pharmaceutical, Health, Other Health, Degenerative disease, Mitigation, Normal, Safety, Aplastic anemia, Country, Market share, High, GlaxoSmithKline, Microcytic, Hoffmann-La Roche, Anemia, Zidovudine, World Bank, Knowledge, Macrocytic anemia, World, Human, Woman, Hospira, Novartis, Epoetin alfa, Technology, Growth, Amgen, HIV, Prevalence, Route of administration, Chronic kidney disease, Pharmacy, Pfizer, Disease, FDA, Blood, REMS, Anti-transglutaminase antibodies, Organic acid, Bayer, Janssen Pharmaceuticals, Hospital, HIV/AIDS, Therapy, Administration, Patient, Macrocytic, Animal, Dietary supplement, Pharmaceutical industry, Lithium, Pyridoxine, Erythropoietin, Deferoxamine

The anemia and other blood disorder drugs market consists of sales of anemia and other blood disorder drugs and related services.

Key Points: 
  • The anemia and other blood disorder drugs market consists of sales of anemia and other blood disorder drugs and related services.
  • The main types of anemia and other blood disorder drugs are iron deficiency anemia, chronic kidney disease anemia, sickle cell anemia and aplastic anemia.
  • Global Anemia And Other Blood Disorder Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.4.
  • Global Anemia And Other Blood Disorder Drugs Market, Segmentation By Anemia Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    7.1.

WICKES GROUP PLC: Director / PDMR Shareholding

Retrieved on: 
Friday, April 1, 2022
Exercise, Normal, LTIP, Achievement, DABP

The options under the LTIP will vest on 31 March 2025 subject to the achievement of performance conditions.

Key Points: 
  • The options under the LTIP will vest on 31 March 2025 subject to the achievement of performance conditions.
  • Vested options will be subject to a two year holding period.
  • If options vest they will normally be exercisable until the tenth anniversary of the Grant Date.
  • The Notification of Dealing Forms for each PDMR can be found below.

WICKES GROUP PLC: Director / PDMR Shareholding

Retrieved on: 
Wednesday, September 29, 2021
LTIP, Normal, Exercise, Achievement, Animal

Vested options will be subject to a two year holding period.

Key Points: 
  • Vested options will be subject to a two year holding period.
  • The options under the LTIP will vest on 28 September 2024 subject to the achievement of performance conditions.
  • If options vest they will normally be exercisable until the tenth anniversary of the Grant Date.
  • The Notification of Dealing Forms for each PDMR can be found below.

365 Connect Explores Staying Distantly Connected in The New Normal During Live Webcast

Retrieved on: 
Friday, June 12, 2020
Six Degrees, Normality, Gree, Connected: The Power of Six Degrees, Normal, Behavior, Human behavior, Articles

The webcast, From Six Degrees to Six Feet of Separation: Staying Distantly Connected in The New Normal, is scheduled to air on June 17, 2020 at 3:00 P.M.

Key Points: 
  • The webcast, From Six Degrees to Six Feet of Separation: Staying Distantly Connected in The New Normal, is scheduled to air on June 17, 2020 at 3:00 P.M.
  • As Americans adjust to the "new normal," people everywhere are altering their behaviors and interactions with others.
  • From Six Degrees to Six Feet of Separation: Staying Distantly Connected in The New Normal will take a closer look at these social shifts and offer solutions for multifamily operators wishing to stay connected with their prospects and residents.
  • The webcast will also discuss how technology is actively reshaping our relationships with peers and business partners.